Research Article
BibTex RIS Cite

Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation

Year 2020, Volume: 3 Issue: 1, 1 - 3, 01.04.2020

Abstract

Objective: Laryngopharyngeal reflux (LPR) is defined as a retrograde flow of gastric contents into the larynx and hypopharynx. However, a possible pathophysiological contribution from nasal resistance has been proposed, according to which increased nasal resistance associated with septal deviation may cause increased respiratory effort, resulting in a more negative intrathoracic pressure, which may, in turn, overcome the upper esophageal sphincter and lead to the retrograde passage of gastric contents. The aim of this study was to investigate whether septal deviation of adequate severity necessitating septoplasty is associated with an increased use of proton pump inhibitors (PPIs) in comparison with the general population.

Material and Methods: This retrospective single-center cohort study investigated the usage of PPIs in patients undergoing septoplasty. Hospital databases were searched to identify patients aged 18-85 years who underwent septoplasty from January 2012 to December 2016. Electronic medical records were reviewed to collect details pertaining to demographic variables, usage of PPIs, smoking and drinking status, and other comorbidities. A control group of subjects who underwent an unrelated procedure (arthroscopy) was also sampled.

Results: The data of 200 patients (29% females, mean age 40.8±14.8 years) who underwent septoplasties were compared with those of 200 control subjects (39.5% females, mean age 45.3±15.0 years) who underwent arthroscopies. The incidence of PPI usage in patients undergoing septoplasty was found to be significantly greater than that in the control group (Pearson’s chi-square 4.7, Odds Ratio [OR] 1.97, p=0.03).

Conclusion: Patients who undergo septoplasty have a significantly increased rate of PPI usage, which suggests that nasal obstruction is associated with LPR and gastroesophageal reflux disease. Further studies are required to explore this association and develop potential therapeutic strategies.

References

  • Siupsinskiene N, Adamonis K, Toohill RJ. Quality of life in laryngopharyngeal reflux patients. Laryngoscope 2007; 117: 480-4.
  • DelGaudio JM, Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope 2005; 115: 946-57.
  • Altman KW, Prufer N, Vaezi MF. A review of clinical practice guidelines for reflux disease: Toward creating a clinical protocol for the otolaryngologist. Laryngoscope 2011; 121: 717-23.
  • Salihefendic N, Zildzic M, Cabric E. Laryngopharyngeal Reflux Disease - LPRD. Med Arch 2017; 71: 215-8.
  • Kim SJ, Kim HY, Jeong JI, Hong SD, Chung SK, Dhong HJ. Changes in the reflux symptom index after multilevel surgery for obstructive sleep apnea. Clin Exp Otorhinolaryngol 2017; 10: 259-64.
  • Fraser-Kirk K. Laryngopharyngeal reflux: A confounding cause of aerodigestive dysfunction. Aust Fam Physician 2017; 46: 34-9. Joo YH, Song YS, Pae CU. Relationship between depression and laryngopharyngeal reflux. Psychiatry Investig 2017; 14: 226-9.
  • Gelardi M, Ciprandi G. Focus on gastroesophageal reflux (GER) and laryngopharyngeal reflux (LPR): New pragmatic insights in clinical practice. J Biol Regul Homeost Agents 2018; 32: 41-7.
  • Wan Y, Yan Y, Ma F, Wang L, Lu P, Maytag A, et al. LPR: How different diagnostic tools shape the outcomes of treatment. J Voice 2014; 28: 362-8.
  • Chen M, Hou C, Chen T, Lin Z, Wang X, Zeng Y. Reflux symptom index and reflux finding score in 91 asymptomatic volunteers. Acta Otolaryngol 2018; 138; 659-63.
  • Wei C. A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 2016; 273: 3795-801.
  • Martinucci I, de Bortoli N, Savarino E, Nacci A, Romeo SO, Bellini M, et al. Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis, 2013; 4: 287-301.
  • Sahin M, Vardar R, Ersin S, Kirazli T, Ogut MF, Akyildiz NS, et al. The effect of antireflux surgery on laryngeal symptoms, findings and voice parameters. Eur Arch Otorhinolaryngol 2015; 272: 3375-83.
  • Dagli E, Yüksel A, Kaya M, Ugur KS, Turkay FC. Association of oral antireflux medication with laryngopharyngeal reflux and nasal resistance. JAMA Otolaryngol Head Neck Surg 2017; 143: 478-83.
  • Mallampati SR, Gatt SP, Gugino LD, Desai SP, Waraksa B, Freiberger D, et al. A clinical sign to predict difficult tracheal intubation: a prospective study. Can Anaesth Soc J 1985; 32: 429-34.
  • Mayhew D, Mendonca V, Murthy BVS. A review of ASA physical status - historical perspectives and modern developments. Anaesthesia 2019; 74: 373-9.
  • Kaliner MA. Classification of nonallergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organ J 2009; 2: 98-101.
There are 16 citations in total.

Details

Primary Language English
Subjects Otorhinolaryngology
Journal Section Original Article
Authors

Eugene Wong This is me 0000-0002-5799-5083

Nathaniel Deboever This is me 0000-0001-8942-5256

Niranjan Sritharan This is me 0000-0003-4916-6610

Narinder Singh This is me 0000-0002-8794-8157

Publication Date April 1, 2020
Published in Issue Year 2020 Volume: 3 Issue: 1

Cite

APA Wong, E., Deboever, N., Sritharan, N., Singh, N. (2020). Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation. European Journal of Rhinology and Allergy, 3(1), 1-3. https://doi.org/10.5152/ejra.2020.235
AMA Wong E, Deboever N, Sritharan N, Singh N. Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation. Eur J Rhinol Allergy. April 2020;3(1):1-3. doi:10.5152/ejra.2020.235
Chicago Wong, Eugene, Nathaniel Deboever, Niranjan Sritharan, and Narinder Singh. “Laryngopharyngeal Reflux Is Associated With Nasal Septal Deviation”. European Journal of Rhinology and Allergy 3, no. 1 (April 2020): 1-3. https://doi.org/10.5152/ejra.2020.235.
EndNote Wong E, Deboever N, Sritharan N, Singh N (April 1, 2020) Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation. European Journal of Rhinology and Allergy 3 1 1–3.
IEEE E. Wong, N. Deboever, N. Sritharan, and N. Singh, “Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation”, Eur J Rhinol Allergy, vol. 3, no. 1, pp. 1–3, 2020, doi: 10.5152/ejra.2020.235.
ISNAD Wong, Eugene et al. “Laryngopharyngeal Reflux Is Associated With Nasal Septal Deviation”. European Journal of Rhinology and Allergy 3/1 (April2020), 1-3. https://doi.org/10.5152/ejra.2020.235.
JAMA Wong E, Deboever N, Sritharan N, Singh N. Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation. Eur J Rhinol Allergy. 2020;3:1–3.
MLA Wong, Eugene et al. “Laryngopharyngeal Reflux Is Associated With Nasal Septal Deviation”. European Journal of Rhinology and Allergy, vol. 3, no. 1, 2020, pp. 1-3, doi:10.5152/ejra.2020.235.
Vancouver Wong E, Deboever N, Sritharan N, Singh N. Laryngopharyngeal Reflux is Associated with Nasal Septal Deviation. Eur J Rhinol Allergy. 2020;3(1):1-3.

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.